SHR-1210
SHR-1210-III-310
Phase 3 small_molecule completed
Quick answer
SHR-1210 for Locally Advanced or Metastatic and Unresectable HCC is a Phase 3 program (small_molecule) at Jian Li with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Jian Li
- Indication
- Locally Advanced or Metastatic and Unresectable HCC
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- completed